Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype‐guided doses in renal …
S Anutrakulchai, C Pongskul… - British Journal of …, 2019 - Wiley Online Library
Aims Although cytochromeP450 (CYP) 3A5 gene polymorphism affects personalized
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype‐guided doses in renal …
S Anutrakulchai, C Pongskul… - British Journal of …, 2019 - search.ebscohost.com
Abstract Aims: Although cytochromeP450 (CYP) 3A5 gene polymorphism affects
personalized tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes …
personalized tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes …
[HTML][HTML] Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype‐guided doses in …
S Anutrakulchai, C Pongskul… - British Journal of …, 2019 - ncbi.nlm.nih.gov
Aims Although cytochromeP450 (CYP) 3A5 gene polymorphism affects personalized
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
[PDF][PDF] Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal …
S Anutrakulchai, C Pongskul, K Kritmetapak… - academia.edu
AIMS Although CytochromeP450 (CYP) 3A5 gene polymorphism affects personalized
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal …
S Anutrakulchai, C Pongskul, K Kritmetapak… - 2019 - pubmed.ncbi.nlm.nih.gov
Aims Although cytochromeP450 (CYP) 3A5 gene polymorphism affects personalized
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal …
S Anutrakulchai, C Pongskul, K Kritmetapak… - British Journal of …, 2019 - europepmc.org
Aims Although cytochromeP450 (CYP) 3A5 gene polymorphism affects personalized
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …
tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be …